External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
CONCLUSIONS: Dose-escalated radiotherapy by BT did not negatively impact long-term adverse effects, substantial problems or QoL compared with EBRT. Future randomised studies using improved EBRT techniques are needed.PMID:37644904 | DOI:10.2340/sju.v58.9571
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Authors: Trude B Wedde Milada C Smaastuen Kari Vatne Melanie Birthe Schulz-Jaavall Sophie D Foss å Wolfgang Lh Lilleby Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Incontinence | Intensity-Modulated Radiation Therapy | Men | Norway Health | PET Scan | Prostate Cancer | Radiation Therapy | Statistics | Study | Urology & Nephrology